About
Adrian Percy is a Venture Partner at DYDX with over 25 years of senior executive experience in biotechnology and chemistry. He currently serves as Director of the PSI at NC State University and was previously CTO of UPL and Head of R&D for the Crop Science division of Bayer, following earlier roles at Rhone-Poulenc and Aventis across France, Germany, and the United States. He holds a Bachelor's in Pharmacology from the University of Liverpool and a Master's in Toxicology and a doctorate in Biochemistry from the University of Birmingham.
Invests in
AgTechBiotech
Experience
- DYDX CapitalFounder & Managing Partnercurrent2021 β presentSilicon Valley
- University of MelbourneVisiting Fellowcurrent2025 β present
- Cime TherapeuticsInvestorcurrent2025 β present
- Citrine InformaticsInvestorcurrent2023 β presentSan Francisco Bay Area
- MatterworksInvestorcurrent2023 β presentCambridge, Massachusetts, United States
- Apparo Inc.Investorcurrent2022 β presentMinnesota, United States
- Applied CarbonInvestorcurrent2022 β presentSilicon Valley, California, United States
- MarketDialDirectorcurrent2021 β presentSalt Lake City, Utah, United States
- Drip CapitalInvestorcurrent2021 β presentPalo Alto, California, United States
- Berkeley YeastInvestorcurrent2021 β presentBerkeley, California, United States
- ClimateAIBoard Observercurrent2021 β present
- Territory FoodsInvestorcurrent2021 β present
- ProducePayInvestorcurrent2021 β presentLos Angeles, California, United States
- EnkoDirectorcurrent2020 β presentMassachusetts, United States
- TovalaDirectorcurrent2020 β presentChicago, Illinois, United States
- American Australian AssociationAmerican Australian Business Council - Membercurrent2018 β presentNew York City Metropolitan Area
- InnitInvestorcurrent2018 β present
- PRIME CoalitionInvestment Advisory Committee Membercurrent2016 β presentSan Francisco Bay Area
- Duke UniversityVisiting Professor2018 β 2025Durham, North Carolina, United States
- Good EggsInvestor2020 β 2024San Francisco Bay Area
Education
- Stanford University Graduate School of BusinessMBA2007 β 2009
- University of MelbournePhD, Genetics
- University of MelbourneBSc (Hons), Genetics and Biochemistry
Skills & more
+9 more
InvestmentsStrategic PartnershipsFinancial ServicesProduct ManagementBusiness DevelopmentMobile DevicesInvestor RelationsFinancial AnalysisBiotechnologyFrom Adrian's professional profile.
Same school
Also attended Stanford University Graduate School of Business1,150
+ 1,144 more
Also attended University of Melbourne186
+ 180 more
Shared employers
Also worked at Cime Therapeutics9
+ 3 more
Also worked at Applied Carbon11
+ 5 more
Also worked at Tovala16
+ 10 more
Also worked at American Australian Association9
+ 3 more
Deals Β· 1
BioLumic, Inc.Board seat
via DYDX Capital Β· filed Dec 2021 Β· $1.3M raise
Attribution from SEC filings, press coverage, and firm rosters.

























